Mark Brosius Sells 63 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) Stock (2024)

Intuitive Surgical, Inc. (NASDAQ:ISRG - Get Free Report) SVP Mark Brosius sold 63 shares of the business's stock in a transaction that occurred on Friday, May 17th. The stock was sold at an average price of $396.19, for a total transaction of $24,959.97. Following the completion of the sale, the senior vice president now owns 295 shares of the company's stock, valued at $116,876.05. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink.

• Intuitive Surgical Leads the Robotic Surgery Movement

Mark Brosius also recently made the following trade(s):

• On Wednesday, May 15th, Mark Brosius sold 175 shares of Intuitive Surgical stock. The stock was sold at an average price of $387.22, for a total transaction of $67,763.50.
• On Monday, May 13th, Mark Brosius sold 175 shares of Intuitive Surgical stock. The stock was sold at an average price of $389.16, for a total transaction of $68,103.00.
• On Thursday, March 7th, Mark Brosius sold 196 shares of Intuitive Surgical stock. The shares were sold at an average price of $393.30, for a total transaction of $77,086.80.
• On Tuesday, March 5th, Mark Brosius sold 196 shares of Intuitive Surgical stock. The shares were sold at an average price of $400.00, for a total transaction of $78,400.00.

Intuitive Surgical Price Performance

ISRG stock traded up $2.39 during trading on Friday, hitting $398.82. 720,293 shares of the stock traded hands, compared to its average volume of 1,263,174. Intuitive Surgical, Inc. has a 1 year low of $254.85 and a 1 year high of $403.76. The firm's 50 day moving average is $384.97 and its two-hundred day moving average is $357.63. The stock has a market cap of $141.46 billion, a price-to-earnings ratio of 71.99, a price-to-earnings-growth ratio of 5.12 and a beta of 1.39.

• Intuitive Surgical Stock Can Trend Much Higher This Year

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last announced its quarterly earnings data on Thursday, April 18th. The medical equipment provider reported $1.50 EPS for the quarter, beating the consensus estimate of $1.40 by $0.10. Intuitive Surgical had a net margin of 27.16% and a return on equity of 12.91%. The company had revenue of $1.89 billion for the quarter, compared to the consensus estimate of $1.87 billion. During the same period in the prior year, the firm posted $1.00 EPS. Intuitive Surgical's revenue for the quarter was up 11.5% on a year-over-year basis. As a group, analysts anticipate that Intuitive Surgical, Inc. will post 4.8 EPS for the current fiscal year.

Analyst Ratings Changes

A number of equities research analysts recently commented on the stock. Stifel Nicolaus upped their price target on shares of Intuitive Surgical from $420.00 to $430.00 and gave the company a "buy" rating in a report on Monday, April 8th. Royal Bank of Canada upped their price objective on shares of Intuitive Surgical from $400.00 to $432.00 and gave the stock an "outperform" rating in a report on Wednesday, January 24th. Jefferies Financial Group upped their price objective on shares of Intuitive Surgical from $365.00 to $375.00 and gave the stock a "hold" rating in a report on Friday, April 19th. Raymond James upped their price objective on shares of Intuitive Surgical from $372.00 to $435.00 and gave the stock an "outperform" rating in a report on Thursday, January 25th. Finally, Wells Fargo & Company upped their price objective on shares of Intuitive Surgical from $363.00 to $416.00 and gave the stock an "overweight" rating in a report on Friday, January 19th. Five analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the company. According to MarketBeat, Intuitive Surgical presently has an average rating of "Moderate Buy" and an average target price of $396.17.

• Johnson & Johnson is as Cheap as it’s Going to Get

Read Our Latest Stock Report on Intuitive Surgical

Institutional Trading of Intuitive Surgical

Institutional investors have recently bought and sold shares of the company. Loring Wolcott & Coolidge Fiduciary Advisors LLP MA boosted its holdings in shares of Intuitive Surgical by 0.3% during the 4th quarter. Loring Wolcott & Coolidge Fiduciary Advisors LLP MA now owns 8,899 shares of the medical equipment provider's stock valued at $3,002,000 after acquiring an additional 27 shares during the last quarter. Advance Capital Management Inc. boosted its holdings in shares of Intuitive Surgical by 3.8% during the 1st quarter. Advance Capital Management Inc. now owns 740 shares of the medical equipment provider's stock valued at $295,000 after acquiring an additional 27 shares during the last quarter. Perigon Wealth Management LLC boosted its holdings in shares of Intuitive Surgical by 0.5% during the 1st quarter. Perigon Wealth Management LLC now owns 5,363 shares of the medical equipment provider's stock valued at $2,140,000 after acquiring an additional 27 shares during the last quarter. Sugarloaf Wealth Management LLC boosted its holdings in shares of Intuitive Surgical by 5.7% during the 1st quarter. Sugarloaf Wealth Management LLC now owns 534 shares of the medical equipment provider's stock valued at $213,000 after acquiring an additional 29 shares during the last quarter. Finally, Sheaff Brock Investment Advisors LLC boosted its holdings in shares of Intuitive Surgical by 1.3% during the 4th quarter. Sheaff Brock Investment Advisors LLC now owns 2,226 shares of the medical equipment provider's stock valued at $751,000 after acquiring an additional 29 shares during the last quarter. 83.64% of the stock is owned by hedge funds and other institutional investors.

About Intuitive Surgical

(Get Free Report)

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.

Featured Stories

• Five stocks we like better than Intuitive Surgical
• How to Calculate Stock Profit
• MarketBeat Week in Review – 5/13 - 5/17
• Most active stocks: Dollar volume vs share volume
• Take-Two Interactive Software Offers 2nd Chance for Investors
• Should You Add These Warren Buffett Stocks to Your Portfolio?
• Deere & Company’s Q2 Report: Strong Revenue, Cautious Outlook

This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. This story was reviewed by InsiderTrades.com's editorial team prior to publication. Please send any questions or comments about this story to [emailprotected].